Nurix Therapeutics, Inc.
Industry: Life Sciences ・ $NRIX on Nasdaq
Insider Sale
+$16,699
-1.89%
Shares
Shares Volume: 1,387 Shares
Average Share Price: $12.04
INSIDER
van Houte Hans
Chief Financial Officer (Officer)
reported on Apr 30 2024
traded on Apr 30 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 71,832 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $37,416.39 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $24,389.44 |
| COMPANY PREVIOUS TRADES |